Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Mediated by a Reversible Drug-Tolerant State
Brenner added, this also meant the mice could not develop any autoimmune disease such as multiple sclerosis. Further tests confirmed that the mice cannot produce any GSH in their T cells, and indicated that several signaling events that directly boost metabolism and increase energy consumption are lacking
Combination with an SGLT2-i is subsidised only after step-wise criteria (not for initial therapy)
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: A randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
US$ 20.86
US$ 25.79
US$ 25.40
US$ 28.43
US$ 25.56
US$ 27.17
US$ 24.50
US$ 27.42
US$ 22.39
